Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Clever Leaves Holdings Inc. (NASDAQ:CLVR) (OTC:CLVRW), a prominent global medical cannabis company announced a strategic partnership with the renowned Dutch seed bank, Paradise Seeds to develop and register high-performance cannabis cultivars in Colombia.
全球知名醫用大麻公司克萊弗·利夫斯控股公司（納斯達克股票代碼：CLVR）（場外交易代碼：CLVRW）宣佈與著名的荷蘭種子庫天堂種子庫建立戰略合作伙伴關係，在哥倫比亞開發和註冊高性能大麻品種。
Through this partnership, Clever Leaves will have an exclusive license to cultivate selected genetics, while Paradise Seeds will make other cultivars available to third parties across Colombia and Latin America.
通過這種合作伙伴關係，Clever Leaves將獲得培育特定遺傳學的獨家許可，而Paradise Seeds將向哥倫比亞和拉丁美洲的第三方提供其他品種。
Andrés Fajardo, CEO of Clever Leaves, said the partnership will expand the company's global footprint and strengthen its portfolio with Paradise's award-winning strains.
Clever Leaves首席執行官安德烈斯·法哈多表示，該合作伙伴關係將擴大公司的全球足跡，並使用天堂獲獎的菌株加強其產品組合。
Luc Krol, founder and CEO of Paradise Seeds also expressed enthusiasm for the collaboration, citing Colombia's favorable conditions for medical cannabis production and the opportunity to advance their strategy of making Paradise varieties accessible globally.
Paradise Seeds的創始人兼首席執行官Luc Krol也表達了對合作的熱情，他列舉了哥倫比亞醫用大麻生產的有利條件以及推進其在全球範圍內提供天堂品種的戰略的機會。
Avicanna's Milestone With Trunerox
Avicanna 與 Trunerox 的里程碑
Toronto-based biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTC:AVCNF) has achieved a significant milestone with the first indication-specific drug registration for Trunerox by INVIMA, Colombia's health authority.
總部位於多倫多的生物製藥公司Avicanna Inc.（多倫多證券交易所股票代碼：AVCN）（場外交易代碼：AVCNF）取得了重要的里程碑，哥倫比亞衛生當局INVIMA首次對Trunerox進行了適應症特異性藥物註冊。
This approval enables Avicanna to manufacture and commercialize Trunerox in Colombia for treating seizures associated with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS). CEO Aras Azadian emphasized the approval as a major step toward serving patients with unmet medical needs.
該批准使Avicanna能夠在哥倫比亞製造和商業化Trunerox，用於治療與倫諾克斯-加斯托特綜合症（LGS）和德拉維特綜合症（DS）相關的癲癇發作。首席執行官阿拉斯·阿扎迪安強調，該批准是朝着爲醫療需求未得到滿足的患者提供服務邁出的重要一步。
Legislative Setbacks In Cannabis Regulation
大麻監管中的立法挫折
The Colombian Congress shelved a bill aimed at regulating adult use and commercialization of cannabis, reflecting deep divisions within the legislative body. Despite support from some lawmakers who argue for regulated legalization to combat drug trafficking and protect youth, the proposition to archive the project received sufficient backing, led by opposition figures who view the measure as conceding to narcotrafficking interests.
哥倫比亞國會擱置了一項旨在監管成人使用和大麻商業化的法案，這反映了立法機構內部的深刻分歧。儘管一些議員支持監管合法化以打擊毒品販運和保護青少年，但將該項目存檔的提議得到了足夠的支持，反對派人士認爲該措施是對毒品販運利益的讓步。
President Gustavo Petro criticized the Senate's decision to stop the legalization measure, arguing it benefits the illegal drug trade and violence.
古斯塔沃·佩特羅總統批評了參議院停止合法化措施的決定，認爲這有利於非法毒品貿易和暴力。
Impact on Cannabis Companies
對大麻公司的影響
The developments in Colombia's cannabis industry and regulatory landscape have implications for companies operating in the country.
哥倫比亞大麻產業和監管格局的發展對在該國運營的公司產生了影響。
Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW), PharmaCielo Ltd (OTC:PCLOF) and Khiron Life Sciences Corp (OTC:KHRNF) are closely monitoring these changes, given their potential impact the cultivation, production and commercialization of cannabis products in Colombia and beyond.
Clever Leaves Holdings Inc.（納斯達克股票代碼：CLVR）（納斯達克股票代碼：CLVRW）、PharmacieLo Ltd（場外交易代碼：PCLOF）和凱龍生命科學公司（場外交易代碼：KHRNF）正在密切關注這些變化，因爲它們可能對哥倫比亞及其他地區大麻產品的種植、生產和商業化產生影響。
As the debate over cannabis regulation continues, industry experts keep an eye out for opportunities and challenges in Colombia's evolving market, with international companies poised to play significant roles in shaping the future of medicinal and potentially recreational cannabis in the region.
隨着關於大麻監管的爭論仍在繼續，行業專家一直在關注哥倫比亞不斷變化的市場中的機遇和挑戰，國際公司準備在塑造該地區藥用大麻和潛在休閒大麻的未來方面發揮重要作用。
Benzinga Cannabis Conferences are coming to Los Angeles. Join the Benzinga Cannabis Market Spotlight: California, and unlock the future of cannabis at the premier networking event in Culver City on February 22. Connect with top industry leaders, gain insider insights into the investment landscape, and shape the evolving markets in California and beyond. Don't miss this chance to be at the forefront of the cannabis industry's growth and innovation! Join now.
Benzinga大麻會議即將在洛杉磯舉行。加入 “Benzinga大麻市場聚焦：加州”，在2月22日在卡爾弗城舉行的頂級社交活動上解鎖大麻的未來。與頂級行業領導者建立聯繫，獲得對投資格局的內幕見解，塑造加利福尼亞及其他地區不斷變化的市場。千萬不要錯過這個站在大麻行業增長和創新最前沿的機會！立即加入。
Photo: AI-Generated Image.
照片：人工智能生成的圖像。
譯文內容由第三人軟體翻譯。